US FDA authorises Moderna, Pfizer updated Covid boosters for 6 months old
THE US Food and Drug Administration on Thursday (Dec 8) authorised updated Covid-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age.
The amended authorisations allow use of Moderna’s bivalent shot in children 6 months through 5 years of age, while the Pfizer/BioNTech vaccine can be given to those aged 6 months through 4 years.
Pfizer’s shot can be administered as the third shot for those eligible and have not completed their primary vaccination series, the agency added. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
DBS, OCBC and UOB shares hit all-time highs as sentiment improves
E-commerce job cuts signal S-E Asia’s shift from scaling to deeper user engagement
Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects
With AI, it’s not about coding better; workers need to think better: Koh Boon Hwee